| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/17/2001 | US6262118 Therapy of type 2 diabetes in a mammal by administering (-) 4-chlorophenyl-(3-trifluoromethylphenoxy)acetic acid derivative |
| 07/17/2001 | US6262117 Method and composition for treating acne |
| 07/17/2001 | US6262116 Transcription therapy for cancers |
| 07/17/2001 | US6262115 Admitting orally into the patient a dosage form of oxybutynin and its pharmaceutically acceptable salt, that is administered once-a-day as sustained-release form for management of incontinence |
| 07/17/2001 | US6262113 IL-8 receptor antagonists |
| 07/17/2001 | US6262112 Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 07/17/2001 | US6262111 Method for increasing the concentration of ascorbic acid in brain tissues of a subject |
| 07/17/2001 | US6262110 Farnesyl-protein transferase inhibitors |
| 07/17/2001 | US6262109 Orally administering an effective amount of natural lycopene |
| 07/17/2001 | US6262108 Treating rheumatic diseases; and allergic, contact and atopic dermatitis |
| 07/17/2001 | US6262107 Conjugated to a water soluble polyglutamic acid polymer |
| 07/17/2001 | US6262106 Adamantanecarboximidamide derivatives and their use as NMDA antagonists |
| 07/17/2001 | US6262105 Method of enhancing hair growth |
| 07/17/2001 | US6262104 Selective delta opioid agonists and antagonists |
| 07/17/2001 | US6262103 Alzheimer's disease. |
| 07/17/2001 | US6262102 Eprosartan monohydrate |
| 07/17/2001 | US6262101 Alpha-pyrrolidine, imidazole and thiophene-substituted styrene derivatives; inhibitors of tumor necrosis factor alpha, nuclear factor kappa b, and phosphodiesterase |
| 07/17/2001 | US6262098 Estrogen receptor modulators |
| 07/17/2001 | US6262096 Aminothiazole inhibitors of cyclin dependent kinases |
| 07/17/2001 | US6262095 Use of tricyclic derivatives of 1,4-dihydro-1,4-dioxo-1H-naphthalene, novel compounds obtained and their application in theraphy |
| 07/17/2001 | US6262094 Anticancer or cytotoxic agent |
| 07/17/2001 | US6262093 E.g., 2-(methoxycarbonylamino)benzimidazole. |
| 07/17/2001 | US6262092 Mutual salt of amlodipine and atorvastatin |
| 07/17/2001 | US6262090 Aminopyridine-containing thiourea inhibitors of herpes viruses |
| 07/17/2001 | US6262089 Using these compounds to treat diseases associated with amyloidosis, such as alzheimer's disease, maturity onset diabetes mellitus, familial amyloid polyneuropathy, scrapie, and kreuzfeld-jacob disease. |
| 07/17/2001 | US6262088 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants |
| 07/17/2001 | US6262087 Indane or dihydroindole derivatives |
| 07/17/2001 | US6262086 6-methoxy-2-(((4-methoxy-3, 5-dimethyl-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole; antisecretory agents |
| 07/17/2001 | US6262085 Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 07/17/2001 | US6262084 Compounds that inhibit the binding of integrins to their receptors |
| 07/17/2001 | US6262082 Diaminopyridine-containing thiourea inhibitors of herpes viruses |
| 07/17/2001 | US6262081 Administering to the mammal a therapeutically effective amount of a combination of: (i) at least one neurotransmitter release enhancer, and (ii) at least one acetylcholinesterase inhibitor. |
| 07/17/2001 | US6262079 Prevention and treatment of cardiovascular pathologies |
| 07/17/2001 | US6262078 Phenoxymethyl piperidine derivatives for the treatment of neuropathic pain |
| 07/17/2001 | US6262077 Composition and method for treating allergic diseases |
| 07/17/2001 | US6262076 Piperidine derivatives, e.g., 1-formyl-n-(2-(4-(5h-dibenzo(a, d)cycloheptene-5-yliden)-1-piperidinyl))ethylisonipecotamide |
| 07/17/2001 | US6262075 Piperidone tachykinin antagonists |
| 07/17/2001 | US6262073 Pharmaceutical methods of use of 5-substituted and 5,5 disubstituted-3,4-dihydroxy-2(5H)-furanones |
| 07/17/2001 | US6262072 Orally administered antimicrobial pharmaceutical formulations of ciprofloxacin |
| 07/17/2001 | US6262071 Methods of use of antimicrobial compounds against pathogenic amycoplasma bacteria |
| 07/17/2001 | US6262068 Lactam derivatives as antiarrhythmic agents |
| 07/17/2001 | US6262067 Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions |
| 07/17/2001 | US6262066 High affinity ligands for nociceptin receptor ORL-1 |
| 07/17/2001 | US6262063 Administering an opioid agent which acts on opiate receptors without delivery into the systemic circulation or to the central nervous system, with the proviso that said agent is not dextromethorphan. |
| 07/17/2001 | US6262062 Method of treating the syndrome of coronary heart disease risk factors in humans |
| 07/17/2001 | US6262061 Treatment of panic attacks |
| 07/17/2001 | US6262060 Treatment of hyperglycaemia, diabetes, obesity or inflammation |
| 07/17/2001 | US6262059 Method of treating a patient having precancerous lesions with quinazoline derivatives |
| 07/17/2001 | US6262057 Pseudopolymorphic forms of 2-[2-[4-[Bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride |
| 07/17/2001 | US6262056 Benzothiophene derivatives and corresponding use and composition |
| 07/17/2001 | US6262054 Combination therapy method for treating breast cancer using edatrexate |
| 07/17/2001 | US6262053 Effective for treating tumor cells and particularly effective to induce apoptosis in leukemia and breast tumor cells. |
| 07/17/2001 | US6262052 Amino acid ester containing azole antifungals |
| 07/17/2001 | US6262050 Topical composition containing capsazepine |
| 07/17/2001 | US6262049 Method of reducing nicotine and tobacco craving in mammals |
| 07/17/2001 | US6262046 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 07/17/2001 | US6262045 Treatment of anxiety; sleep disorder; epilepsy; spasticity; muscle contracture or an extrapyramidal syndrom; inducing or maintaining anaesthesia |
| 07/17/2001 | US6262043 Show inhibitory activity against steroid sulfatase and are useful in treating or preventing hormone dependent diseases. |
| 07/17/2001 | US6262042 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 07/17/2001 | US6262041 Topically administering the compound 26, 27-hexafluoro-1,25-dihydroxy vitamin d3 to the skin |
| 07/17/2001 | US6262040 Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF) |
| 07/17/2001 | US6262033 Remedy for diseases associated with NF-κB |
| 07/17/2001 | US6262032 Method of destroying hyperproliferative cells by combined p53 and taxoid treatment |
| 07/17/2001 | US6262031 Method for treating pediculosis capitisinfestation |
| 07/17/2001 | US6262028 CONTAINING OXY-SUBSTITUTED AMIDINOBENZYL DERIVATIVES OF DIPEPTIDES FROM CYCLOHEXYLGLYCINE AND AZETIDINE-2-CARBOXYLIC ACID; ximelagatran |
| 07/17/2001 | US6262025 Their encoded protein products, as well as derivatives and analogs thereof. |
| 07/17/2001 | US6262021 Wounds of the skin, bone, mucus, tendons, muscles or connective tissue in mammals. |
| 07/17/2001 | US6262019 Method of treatment of glutathione deficient mammals |
| 07/17/2001 | US6262017 Peptides for altering osteoblast adhesion |
| 07/17/2001 | US6261840 Nucleotide sequences for gene expression inhibition of protein phosphatase 1b, a protein tyrosine phosphatase; diagnosis and antisense therapy of related diseases |
| 07/17/2001 | US6261839 Method for the induction of a NK cell-mediated immune response |
| 07/17/2001 | US6261826 Antibiotic TKR2648 and process for producing the same |
| 07/17/2001 | US6261803 Process for preparing functional recombinant tissue factor |
| 07/17/2001 | US6261774 Truncation selex method |
| 07/17/2001 | US6261606 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 07/17/2001 | US6261602 Pharmaceutical composition for rapid suspension in aqueous media |
| 07/17/2001 | US6261601 Orally administered controlled drug delivery system providing temporal and spatial control |
| 07/17/2001 | US6261600 Mixture containing neutralized alkaline compound |
| 07/17/2001 | US6261599 Sustained release |
| 07/17/2001 | US6261598 Carotenoid formulations, comprising a mixture of B-carotens, lycopene and lutein |
| 07/17/2001 | US6261596 Method to provide for production of hair coloring pigments in hair follicles |
| 07/17/2001 | US6261589 Dietary supplement nutrient soft drink composition with psychoactive effect |
| 07/17/2001 | US6261575 Skin-care agent for ageing skin |
| 07/17/2001 | US6261565 Plant extract |
| 07/17/2001 | US6261561 Administering intimin or fusion protein |
| 07/17/2001 | US6261559 Inhalation device |
| 07/17/2001 | US6261547 Solutions for vision defects, anesthetics |
| 07/17/2001 | US6261546 Methods and compositions for stabilizing acetylcholine compositions |
| 07/17/2001 | US6261544 Poly(hydroxy acid)/polymer conjugates for skin applications |
| 07/17/2001 | US6261279 Surgical irrigation solution and method for inhibition of pain and inflammation |
| 07/17/2001 | CA2331167A1 Augmentation method for antitumor activity of substance containing amygdalin, composition containing augmented amygdalin contained substance, method for assessing antitumor efficacy of treatment for amygdalin contained substance and method for assessing antitumor substance containing amygdalin |
| 07/17/2001 | CA2261500C Stable oxaliplatin solutions and their use in cytostatic antineoplastic treatment |
| 07/17/2001 | CA2223023C N-hydroxyureas as antiinflammatory agents |
| 07/17/2001 | CA2197320C Stable water-in-oil emulsion system |
| 07/17/2001 | CA2173543C Ceramide-type compounds, process for their preparation and uses thereof |
| 07/17/2001 | CA2160961C New tricyclic amide compounds, process for preparing the same and pharmaceutical compositions containing them |
| 07/17/2001 | CA2157860C 5,6-dihydro-4h-imidazo [4,5,1-ij] quinolines, processes for their preparation, their use as medicaments, and intermediate compounds |
| 07/17/2001 | CA2130515C New 11-benzaldoxime-17.beta.-methoxy-17.alpha.-methoxymethylestradiene derivatives, methods for their production and pharmaceuticals containing these substances |
| 07/17/2001 | CA2126911C Isolation and structure of spongistatin 2, spongistatin 3, spongistatin 4 and spongistatin 6 |
| 07/17/2001 | CA2126910C Isolation and structure of spongistatins 5, 7, 8, and 9 |